10x Genomics and Syncell streamline cutting-edge ... GeneDx has also partnered with the New York Center for Rare Diseases at Montefiore, PacBio, and Google Health to deliver genetic diagnoses ...

PacBio and 10x bounced back due to factors beyond the NIH, namely earnings reports that delivered to investors both bad news and good about the companies. 10x finished the fourth quarter of 2024 ...

In Monday’s trading, instrument manufacturers Pacific Biosciences and 10x Genomics each saw their stock prices dive by 13% to 14%, while industry giant Illumina—still recovering from being ...

PacBio’s earnings surpassed the Zacks Consensus ... which is the first SBB short-read sequencing service provider. Joining the 10X Genomics Compatible Partner program integrates Onso into ...

such as joining the 10x Genomics Compatible Partner Program and setting up a collaborative laboratory in Singapore. Looking forward, the management of Pacific Biosciences of California ...

Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22. Operator: Good day and welcome to the PacBio Third Quarter 2024 Earnings ...

Savant covers the Healthcare sector, focusing on stocks such as 10x Genomics ... Begin your TipRanks Premium journey today. Pacific Biosciences (PACB) Company Description: Pacific Biosciences ...

PacBio (Nasdaq: PACB), announced the inclusion of the Onso short-read sequencing platform in the 10x Genomics Compatible Partner Program. The 10x Genomics Compatible Partner Program recognizes ...

PacBio (PACB), a leading developer of high-quality, highly accurate genomic sequencing solutions, today announced the inclusion of the Onso short-read sequencing platform in the 10x Genomics ...

Oct. 22, 2024 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate genomic sequencing solutions, today announced the inclusion of the Onso short-read ...